Thank Dew for bringing OPXA to my attention in this post !!
Posting and doing real DD on Elan gives one expertise in MS, especially ARR numbers, and this is what I advised you in my two previous replies -
"That ARR looks very good. It is absolutely essential that a Phase III be done."
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=32310307
"with an ARR benefit in the MS trial like that, this one is going all the way back to where it fell from.... I loaded up @ 22c and 19c"
http://investorshub.advfn.com/boards/replies.aspx?msg=32302329
Well on Friday this one ripped to almost $3 (yep a 15-bagger) - and that is without even any announcement of a new MS trial. Instead - outstanding science gets rewarded -
http://investorshub.advfn.com/boards/board.aspx?board_id=8741
Today it has pulled back somewhat - just wait for the MS trial, in time.
So Dew tell us what Zebra's Law means again? Is it about biotech science?
An Elan MIRACLE - linktext
FEATURED DaBaby and Stunna 4 Vegas's "NO DRIBBLE" Joins Music Licensing, Inc.'s Portfolio • Jun 7, 2024 10:15 AM
Mushrooms Inc. (OTC: MSRM) Announces Significant Share Buy Back by the Board Director and New Strategic Initiatives. • MSRM • Jun 5, 2024 1:32 PM
Hydromer Announces Launch of HydroThrombX Medical Device Coating Technology • HYDI • Jun 5, 2024 10:24 AM
Dr. Michael Dent Finances $1 Million to Drive HealthLynked's Healthcare Transformation • HLYK • Jun 5, 2024 8:00 AM
Avant Technologies Enters Binding LOI to Purchase Dozens of High-Performance, Immersible, AI-Powered Servers • AVAI • Jun 5, 2024 8:00 AM
IQST - iQSTEL Announces $290 Million 2024 Annual Revenue Forecast • IQST • Jun 4, 2024 1:43 PM